Why the study?
What are the risk factors and prognostic value of anti-depressant drug therapy in adult congenital heart disease?
What are the risk factors and prognostic value of anti-depressant drug therapy in adult congenital heart disease?
Answers are grounded in this paper and cite their sources.
In adult congenital heart disease, male patients requiring anti-depressant therapy have an increased mortality risk and worse medical adherence, highlighting a need for targeted psychosocial interventions.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Diller et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: